The T1D Exchange, with lead sponsorship from JDRF and The Leona M. and Harry B. Helmsley Charitable Trust, has announced ten finalists for the 2018 Diabetes Innovation Challenge, a global competition to identify, nurture and fast-track innovative scientific and clinical solutions for diabetes. The challenge will award $250,000 in cash and in-kind services, which will be divided among the three winners, one of which will be a People’s Choice award winner who gets the most votes during the public voting period, which runs from March 23 to May 19. The live event, at which the finalists will make a formal presentation, will take place May 21, and the winners will be announced immediately afterwards.

A total of 60 proposals were received, and 30 semi-finalists were reviewed by a panel of experts, including two of JDRF’s scientists—Julia L. Greenstein, Ph.D., vice president, research strategy, and Andrew Rakeman, Ph.D., assistant vice president, research.

“The academic teams and early-stage companies are providing real-life solutions for the diabetes community,” says Dr. Greenstein. “It is a great opportunity to see what’s around the corner, and JDRF was happy to play a part in this competition to bring innovative new therapies and devices to people with T1D.”

Go here to read more about the 2018 Diabetes Innovation Challenge.